Versatile Synthesis of Polymer-Temozolomide Conjugates

Area of Science:

• Polymer Chemistry
• Medicinal Chemistry
• Materials Science

Background:

• Glioblastoma multiforme is an aggressive brain tumor with limited treatment options.
• Temozolomide (TMZ) is a key chemotherapeutic agent for glioblastoma, but its delivery and efficacy can be improved.
• Polymeric prodrugs offer a strategy to enhance drug solubility, stability, and targeted delivery.

Purpose of the Study:

• To develop a novel and versatile synthesis for creating polymer prodrugs of Temozolomide (TMZ).
• To conjugate the anticancer drug TMZ covalently with poly(2-methacryloyloxyethyl phosphorylcholine) (polyMPC).
• To achieve high drug loading and maintain structural integrity of the drug within the polymer conjugate.

Main Methods:

• Controlled free radical copolymerization of a TMZ-substituted methacrylate monomer with MPC monomer.
• Characterization of the resulting polymer-TMZ conjugates using NMR and UV-vis spectroscopy.
• Molecular weight distribution analysis using gel permeation chromatography (GPC).

Main Results:

• Successfully synthesized water-soluble polyMPC-TMZ conjugates with high TMZ loading (>50 mol %).
• Confirmed the structural integrity of the conjugated TMZ moieties post-polymerization.
• Demonstrated controlled polymerization yielding narrow molecular weight distributions for the polymer-TMZ conjugates.

Conclusions:

• A versatile synthetic route for polyMPC-TMZ polymer prodrugs was established.
• The developed conjugates show promise for improved glioblastoma treatment strategies.
• This approach enables the formulation of diverse polymeric TMZ-based structures for therapeutic applications.